Decreases in global cognition and executive function, as well as long-term persistent declines in those cognitive domains, are associated with incident HF.

There is increased use of quadruple medical therapy among patients following implementation of an HF quality improvement initiative.

The win ratio is a method for analyzing a hierarchical composite outcome. It has been most widely used in randomized clinical trials (RCTs) in cardiovascular disease. We performed a review of ...

Left ventricular ejection fraction (LVEF) has long served as a central measure in assessing cardiac function and guiding heart failure (HF) management. However, limitations in its diagnostic precision ...

The statement is published in the European Journal of Heart Failure. Left ventricular ejection fraction (LVEF) has long served as a central measure in assessing cardiac function and guiding heart ...

Preventing onset and development of heart failure with preserved ejection fraction Date: April 15, 2025 Source: Baylor College of Medicine Summary: An international team of researchers has ...

About The Study: Among patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction in the Finerenone Trial to Investigate Efficacy and Safety ...

How would you further evaluate and treat this patient? Heart failure with preserved ejection fraction is a heterogeneous syndrome. The diagnosis of the condition requires ruling out potential ...

Gregg C. Fonarow et al, Heart Failure With Preserved Ejection Fraction—A Role for Invasive Hemodynamics, JAMA Cardiology (2024). DOI: 10.1001/jamacardio.2024.3764 Journal information: JAMA ...

Patients treated with tirzepatide also experienced notable improvements in heart failure symptoms and physical limitations. The results were published in The New England Journal of Medicine ...

A low ejection fraction lets a doctor know that the active pumping phase of the heart isn't working. It's usually tied to some, but not all, types of heart failure. Heart failure with a low EF is ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been ...